- Email: [email protected]
Contributors to volume 25
Contributors to Volume 25
Article numbers are in parentheses following the names of contributors. Affiliations listed are current.
MARJORIE A. ARIANO (21), Department of Neuroscience, The Chicago Medical School, North Chicago, Illinois 60064 JUAN A. BALLESTEROS (19), Departments of Physiology and Biophysics, Mount Sinai School of Medicine, New York, New York 10029 DIANE L. BARBER (12), Department of Stomatology, School of Dentistry, University of California, San Francisco, California 94143 CLAUDIA BOUVIER(5), College of Pharmacy, Oregon State University, Portland, Oregon 97331 JAMES R. BUNZOW (5), Vollum Institute for Advanced Biomedical Research, Oregon Health Sciences University, Portland, Oregon 97201 MARI R. CANDELORE (14), Department of Molecular Pharmacology and Biochemistry, Merck Research Laboratories, Rahway, New Jersey 07065 CYNTHIA J. L. CARRUTHERS (17), Laboratory of Molecular Biology and Biochemistry, Howard Hughes Medical Institute, Rockefeller University, New York, New York 10021 MICHAEL CASCIO (10), Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15219 BRIAN J. CILIAX (20), Department of Neurology, Emory University School of Medicine, Atlanta, Georgia 30322 J. DAVIDSON (8), Regulatory Peptide Research Unit, Department of Chemical Pathology, University of Cape Town Medical School, Observatory 7925, Cape Town, South Africa SHARON EDMUNDS (20), Department of Neurology, Emory University School of Medicine, Atlanta, Georgia 30322 C. FLANAGAN (8), Regulatory Peptide Research Unit, Department of Medicine, University of Cape Town Medical School, Observatory 7925, Cape Town, South Africa TUNG MING FONG (14), Department of Molecular Pharmacology, and Biochemistry, Merck Research Laboratories, Rahway, New Jersey 07065 ix
CONTRIBUTORS TO VOLUME25 BOAZ GILLO (6), Department of Physiology, Hadassah Medical School, Jerusalem 91120, Israel DAVID K. GRANDY(5), Vollum Institute for Advanced Biomedical Research and Department of Cell Biology and Anatomy, Oregon Health Sciences University, Portland, Oregon 97201 JEAN-GI~RARD GUILLET (18), INSERM U152, Institut Cochin de G6n6tique Mol6culaire, F-75074 Paris, France CRAI6 HEILMAN (20), Department of Neurology, Emory University School of Medicine, Atlanta, Georgia 30322 STEVEN M. HERSCH (20), Department of Neurology, Emory University School of Medicine, Atlanta, Georgia 30322 JOHAN HOEBEKE (18), Laboratoire d'Enzymologie et de Chimie des Proteines, Faculte de Medecine, F-37032 Tours Cedex, France MOSHE JAKUBOWSKI (22), Department of Obstetrics, Gynecology, and Reproductive Biology, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts 02215 ROLE H. JOHO (4), Department of Cell Biology and Neuroscience, The University of Texas Southwestern Medical Center, Dallas, Texas 75235 EWEN F. KIRKNESS(7), Department of Molecular and Cellular Biology, The Institute for Genomic Research, Gaithersburg, Maryland 20878 BRIAN K. KOBILKA (15), Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, California 94305 ALLAN I. LEVEY (20), Department of Neurology, Emory University School of Medicine, Atlanta, Georgia 30322 CRAIG C. MALBON (23), Department of Molecular Pharmacology, School of Medicine, State University of New York at Stony Brook, Stony Brook, New York 11794 DARIA MALEK (16), Institut fur Pharmakologie und Toxikologie, Universit~it Ulm, D-89069 Ulm, Germany R. P. MILLAR(8), Regulatory Peptide Research Unit, Department of Chemical Pathology, University of Cape Town Medical School, Observatory 7925, Cape Town, South Africa ANITA MISRA-PRESS (13), Vollum Institute for Advanced Biomedical Research, Oregon Health Sciences University, Portland, Oregon 97201
CONTRIBUTORS TO VOLUME 25
xi
CHRISTOPHER M. MOXHAM (23), Department of Molecular Pharmacology, School of Medicine, State University of New York at Stony Brook, Stony Brook, New York 11794 GERALD MONCH (16), The Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, Sydney, New South Wales 2010, Australia RANDALL B. MURPHY (2), Department of Chemistry, New York University, New York, New York 10003 KIM A. NEVE (9, 12), Veteran Affairs Medical Center, and Department of Psychiatry and Pharmacology, Oregon Health Sciences University, Portland, Oregon 97201 RACHEL L. NEVE (9), Department of Genetics, Harvard Medical School and McLean Hospital, Belmont, Massachusetts 02178 JOHN C. OWICKI (1 1), Molecular Devices Corporation, Sunnyvale, California 94089
DIETER PALM (16), Theodor-Boveri-Institut, Physiologische Chemie I, Universitfit Wurzburg, D-97074 Wurzburg, Germany MING-GuI PAN (13), Cardiovascular Research Institute, University of California at San Francisco, San Francisco, California 94143 MARY P. ROSSER(12), Department of Biochemical Screening, Bristol-Myers Squibb Company, Wallingford, Connecticut 06492 CARMEN SAEZ (5), Department of Anatomical Pathology, University Hospital Virgen del Rocio, Sevilla, Spain THOMAS P. SAKMAR(17), Laboratory of Molecular Biology and Biochemistry, Howard Hughes Medical Institute, Rockefeller University, New York, New York 10021 JOHN A. SALON (11), Synaptic Pharmaceutical Corporation, Paramus, New Jersey 07652 DAVID I. SCHUSTER (2), Department of Chemistry, New York University, New York, New York 10003 STUART C. SEALFON (1), Dr. Arthur M. Fishberg Research Center in Neurobiology, and Department of Neurology, Mount Sinai School of Medicine, New York, New York 10029 MEILING SHIH (23), Department of Molecular Pharmacology, School of Medicine, State University of New York at Stony Brook, Stony Brook, New York 11794
xii
CONTRIBUTORS TO VOLUME 25
DAVID R. SIBLEY (21), Molecular Neuropharmacology Section, National Institutes for Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland 20892 PHILIP J. S. STORK (13), Vollum Institute for Advanced Biomedical Research, Oregon Health Sciences University, Portland, Oregon 97201 CATHERINE D. STRADER (14), Department of Molecular Pharmacology and Biochemistry, Merck Research Laboratories, Rahway, New Jersey 07065 A. DONNY STROSBERC(18), UPR 0415, Immunopharmacologic Mol6culaire, Institut Cochin de G6n6tique Mol6culaire, F-75014 Paris, France SANKURATRI SURYANARAYANA(15), CV Therapeutics, Palo Alto, California 94304 MANAMI TSUTSUMI (6), Dr. Arthur M. Fishberg Research Center in Neurobiology, Mount Sinai School of Medicine, New York, New York 10029 J. CRAIG VENTER (7), Department of Gene Discovery and Physiology, The Institute for Genomic Research, Gaithersburg, Maryland 20878 I. WAKEFIELD(8), Regulatory Peptide Research Unit, Department of Chemical Pathology, University of Cape Town Medical School, Observatory 7925, Cape Town, South Africa MICHAEL J. WALSH (3), Department of Neurology, Mount Sinai School of Medicine, New York, New York 10029 HAREL WEINSTEIN (19), Departments of Physiology and Biophysics, Mount Sinai School of Medicine, New York, New York 10029 HUI-JUAN ZHANG (4), Department of Cell Biology and Neuroscience, The University of Texas Southwestern Medical Center, Dallas, Texas 75235 QuN-YONG ZHOU (5), Howard Hughes Medical Institute, University of
Washington, Seattle, Washington 98195 ROGER D. ZUHLKE (4), Department of Cell Biology and Neuroscience, The University of Texas Southwestern Medical Center, Dallas, Texas 75235
Article numbers are in parentheses following the names of contributors. Affiliations listed are current.
MARJORIE A. ARIANO (21), Department of Neuroscience, The Chicago Medical School, North Chicago, Illinois 60064 JUAN A. BALLESTEROS (19), Departments of Physiology and Biophysics, Mount Sinai School of Medicine, New York, New York 10029 DIANE L. BARBER (12), Department of Stomatology, School of Dentistry, University of California, San Francisco, California 94143 CLAUDIA BOUVIER(5), College of Pharmacy, Oregon State University, Portland, Oregon 97331 JAMES R. BUNZOW (5), Vollum Institute for Advanced Biomedical Research, Oregon Health Sciences University, Portland, Oregon 97201 MARI R. CANDELORE (14), Department of Molecular Pharmacology and Biochemistry, Merck Research Laboratories, Rahway, New Jersey 07065 CYNTHIA J. L. CARRUTHERS (17), Laboratory of Molecular Biology and Biochemistry, Howard Hughes Medical Institute, Rockefeller University, New York, New York 10021 MICHAEL CASCIO (10), Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15219 BRIAN J. CILIAX (20), Department of Neurology, Emory University School of Medicine, Atlanta, Georgia 30322 J. DAVIDSON (8), Regulatory Peptide Research Unit, Department of Chemical Pathology, University of Cape Town Medical School, Observatory 7925, Cape Town, South Africa SHARON EDMUNDS (20), Department of Neurology, Emory University School of Medicine, Atlanta, Georgia 30322 C. FLANAGAN (8), Regulatory Peptide Research Unit, Department of Medicine, University of Cape Town Medical School, Observatory 7925, Cape Town, South Africa TUNG MING FONG (14), Department of Molecular Pharmacology, and Biochemistry, Merck Research Laboratories, Rahway, New Jersey 07065 ix
CONTRIBUTORS TO VOLUME25 BOAZ GILLO (6), Department of Physiology, Hadassah Medical School, Jerusalem 91120, Israel DAVID K. GRANDY(5), Vollum Institute for Advanced Biomedical Research and Department of Cell Biology and Anatomy, Oregon Health Sciences University, Portland, Oregon 97201 JEAN-GI~RARD GUILLET (18), INSERM U152, Institut Cochin de G6n6tique Mol6culaire, F-75074 Paris, France CRAI6 HEILMAN (20), Department of Neurology, Emory University School of Medicine, Atlanta, Georgia 30322 STEVEN M. HERSCH (20), Department of Neurology, Emory University School of Medicine, Atlanta, Georgia 30322 JOHAN HOEBEKE (18), Laboratoire d'Enzymologie et de Chimie des Proteines, Faculte de Medecine, F-37032 Tours Cedex, France MOSHE JAKUBOWSKI (22), Department of Obstetrics, Gynecology, and Reproductive Biology, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts 02215 ROLE H. JOHO (4), Department of Cell Biology and Neuroscience, The University of Texas Southwestern Medical Center, Dallas, Texas 75235 EWEN F. KIRKNESS(7), Department of Molecular and Cellular Biology, The Institute for Genomic Research, Gaithersburg, Maryland 20878 BRIAN K. KOBILKA (15), Howard Hughes Medical Institute, Stanford University Medical Center, Stanford, California 94305 ALLAN I. LEVEY (20), Department of Neurology, Emory University School of Medicine, Atlanta, Georgia 30322 CRAIG C. MALBON (23), Department of Molecular Pharmacology, School of Medicine, State University of New York at Stony Brook, Stony Brook, New York 11794 DARIA MALEK (16), Institut fur Pharmakologie und Toxikologie, Universit~it Ulm, D-89069 Ulm, Germany R. P. MILLAR(8), Regulatory Peptide Research Unit, Department of Chemical Pathology, University of Cape Town Medical School, Observatory 7925, Cape Town, South Africa ANITA MISRA-PRESS (13), Vollum Institute for Advanced Biomedical Research, Oregon Health Sciences University, Portland, Oregon 97201
CONTRIBUTORS TO VOLUME 25
xi
CHRISTOPHER M. MOXHAM (23), Department of Molecular Pharmacology, School of Medicine, State University of New York at Stony Brook, Stony Brook, New York 11794 GERALD MONCH (16), The Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, Sydney, New South Wales 2010, Australia RANDALL B. MURPHY (2), Department of Chemistry, New York University, New York, New York 10003 KIM A. NEVE (9, 12), Veteran Affairs Medical Center, and Department of Psychiatry and Pharmacology, Oregon Health Sciences University, Portland, Oregon 97201 RACHEL L. NEVE (9), Department of Genetics, Harvard Medical School and McLean Hospital, Belmont, Massachusetts 02178 JOHN C. OWICKI (1 1), Molecular Devices Corporation, Sunnyvale, California 94089
DIETER PALM (16), Theodor-Boveri-Institut, Physiologische Chemie I, Universitfit Wurzburg, D-97074 Wurzburg, Germany MING-GuI PAN (13), Cardiovascular Research Institute, University of California at San Francisco, San Francisco, California 94143 MARY P. ROSSER(12), Department of Biochemical Screening, Bristol-Myers Squibb Company, Wallingford, Connecticut 06492 CARMEN SAEZ (5), Department of Anatomical Pathology, University Hospital Virgen del Rocio, Sevilla, Spain THOMAS P. SAKMAR(17), Laboratory of Molecular Biology and Biochemistry, Howard Hughes Medical Institute, Rockefeller University, New York, New York 10021 JOHN A. SALON (11), Synaptic Pharmaceutical Corporation, Paramus, New Jersey 07652 DAVID I. SCHUSTER (2), Department of Chemistry, New York University, New York, New York 10003 STUART C. SEALFON (1), Dr. Arthur M. Fishberg Research Center in Neurobiology, and Department of Neurology, Mount Sinai School of Medicine, New York, New York 10029 MEILING SHIH (23), Department of Molecular Pharmacology, School of Medicine, State University of New York at Stony Brook, Stony Brook, New York 11794
xii
CONTRIBUTORS TO VOLUME 25
DAVID R. SIBLEY (21), Molecular Neuropharmacology Section, National Institutes for Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland 20892 PHILIP J. S. STORK (13), Vollum Institute for Advanced Biomedical Research, Oregon Health Sciences University, Portland, Oregon 97201 CATHERINE D. STRADER (14), Department of Molecular Pharmacology and Biochemistry, Merck Research Laboratories, Rahway, New Jersey 07065 A. DONNY STROSBERC(18), UPR 0415, Immunopharmacologic Mol6culaire, Institut Cochin de G6n6tique Mol6culaire, F-75014 Paris, France SANKURATRI SURYANARAYANA(15), CV Therapeutics, Palo Alto, California 94304 MANAMI TSUTSUMI (6), Dr. Arthur M. Fishberg Research Center in Neurobiology, Mount Sinai School of Medicine, New York, New York 10029 J. CRAIG VENTER (7), Department of Gene Discovery and Physiology, The Institute for Genomic Research, Gaithersburg, Maryland 20878 I. WAKEFIELD(8), Regulatory Peptide Research Unit, Department of Chemical Pathology, University of Cape Town Medical School, Observatory 7925, Cape Town, South Africa MICHAEL J. WALSH (3), Department of Neurology, Mount Sinai School of Medicine, New York, New York 10029 HAREL WEINSTEIN (19), Departments of Physiology and Biophysics, Mount Sinai School of Medicine, New York, New York 10029 HUI-JUAN ZHANG (4), Department of Cell Biology and Neuroscience, The University of Texas Southwestern Medical Center, Dallas, Texas 75235 QuN-YONG ZHOU (5), Howard Hughes Medical Institute, University of
Washington, Seattle, Washington 98195 ROGER D. ZUHLKE (4), Department of Cell Biology and Neuroscience, The University of Texas Southwestern Medical Center, Dallas, Texas 75235